Study of Safety and Efficacy of Brolucizumab 6 mg Drug Product Intended for Commercialization in Patients With nAMD

PHASE3CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

September 6, 2018

Study Completion Date

September 6, 2018

Conditions
Neovascular Age-related Macular Degeneration
Interventions
DRUG

Brolucizumab 6 mg

Administered as opthalmic solution for an intravitreal injection to the study eye

DRUG

Aflibercept 2 mg

Administered as an opthalmic solution for intravitreal injection to the study eye

Trial Locations (65)

11967

Novartis Investigative Site, Shirley

13224

Novartis Investigative Site, Syracuse

14620

Novartis Investigative Site, Rochester

14642

Novartis Investigative Site, Rochester

17011

Novartis Investigative Site, Camp Hill

20186

Novartis Investigative Site, Warrenton

20602

Novartis Investigative Site, Waldorf

23235

Novartis Investigative Site, Richmond

26506

Novartis Investigative Site, Morgantown

28210

Novartis Investigative Site, Charlotte

28387

Novartis Investigative Site, Southern Pines

32308

Novartis Investigative Site, Tallahassee

32503

Novartis Investigative Site, Pensacola

32701

Novartis Investigative Site, Altamonte Springs

32960

Novartis Investigative Site, Vero Beach

33064

Novartis Investigative Site, Deerfield Beach

33410

Novartis Investigative Site, Palm Beach Gardens

33880

Novartis Investigative Site, Winter Haven

34239

Novartis Investigative Site, Sarasota

34474

Novartis Investigative Site, Ocala

37203

Novartis Investigative Site, Nashville

43016

Novartis Investigative Site, Dublin

44122

Novartis Investigative Site, Cleveland

44195

Novartis Investigative Site, Cleveland

45014

Novartis Investigative Site, Fairfield

46280

Novartis Investigative Site, Indianapolis

53226

Novartis Investigative Site, Milwaukee

61704

Novartis Investigative Site, Bloomington

66204

Novartis Investigative Site, Shawnee Mission

66211

Novartis Investigative Site, Leawood

75093

Novartis Investigative Site, Plano

76104

Novartis Investigative Site, Fort Worth

77025

Novartis Investigative Site, Houston

77030

Novartis Investigative Site, Houston

78215

Novartis Investigative Site, San Antonio

78240

Novartis Investigative Site, San Antonio

78731

Novartis Investigative Site, Austin

79606

Novartis Investigative Site, Abilene

80401

Novartis Investigative Site, Golden

80909

Novartis Investigative Site, Colorado Springs

83713

Novartis Investigative Site, Boise

85014

Novartis Investigative Site, Phoenix

85381

Novartis Investigative Site, Peoria

87102

Novartis Investigative Site, Albuquerque

89144

Novartis Investigative Site, Las Vegas

89502

Novartis Investigative Site, Reno

91006

Novartis Investigative Site, Arcadia

92093

Novartis Investigative Site, La Jolla

92354

Novartis Investigative Site, Loma Linda

92374

Novartis Investigative Site, Redlands

92647

Novartis Investigative Site, Huntington Beach

94040

Novartis Investigative Site, Mountain View

94609

Novartis Investigative Site, Oakland

95841

Novartis Investigative Site, Sacramento

98383

Novartis Investigative Site, Silverdale

98467

Novartis Investigative Site, University Place

99204

Novartis Investigative Site, Spokane

06606

Novartis Investigative Site, Bridgeport

06320

Novartis Investigative Site, New London

33912-7125

Novartis Investigative Site, Fort Myers

04102

Novartis Investigative Site, Portland

21237-4350

Novartis Investigative Site, Baltimore

08755

Novartis Investigative Site, Toms River

00612

Novartis Investigative Site, Arecibo

00907

Novartis Investigative Site, San Juan

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY